Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Nov 15;320(Pt 1):335–341. doi: 10.1042/bj3200335

Cleavage of the thrombin receptor: identification of potential activators and inactivators.

M A Parry 1, T Myles 1, J Tschopp 1, S R Stone 1
PMCID: PMC1217936  PMID: 8947506

Abstract

The kinetic parameters were determined for the hydrolysis of a peptide based on the activation site of the thrombin receptor (residues 38-60) by thrombin and 12 other proteases. The kcat and Km values for the cleavage of this peptide (TR39-40) by thrombin were 107 s-1 and 1.3 microM; the kcat/Km of TR39-40 is among the highest observed for thrombin. A model is presented that reconciles the parameters for cleavage of the peptide with the concentration dependence of cellular responses to thrombin. Cleavage of TR39-40 was not specific for thrombin. The pancreatic proteases trypsin and chymotrypsin hydrolysed TR39-40 efficiently (kcat/Km > 10(6) M-1.s-1). Whereas trypsin cleaved TR39-40 at the thrombin activation site (Arg41-Ser42), chymotrypsin hydrolysed the peptide after Phe43. This chymotryptic cleavage would result in inactivation of the receptor. The efficient cleavage of TR39-40 by chymotrypsin (kcat/Km approximately 10(6) M-1.s-1) was predominantly due to a low Km value (2.8 microM). The proteases factor Xa, plasmin, plasma kallikrein, activated protein C and granzyme A also hydrolysed TR39-40 at the Arg41-Ser43 bond, but exhibited kcat/Km values that were at least 10(3)-fold lower than that observed with thrombin. Both tissue and urokinase plasminogen activators as well as granzyme B and neutrophil elastase were unable to cleave TR39-60 at appreciable rates. However, neutrophil cathepsin G hydrolysed the receptor peptide after Phe55. Like the chymotryptic cleavage, this cleavage would lead to inactivation of the receptor, but the cathepsin G reaction was markedly less efficient; the kcat/K(m) value was almost four orders of magnitude lower than that for thrombin. In addition to the above cleavage sites, a secondary site for thrombin and other arginine-specific proteases was identified at Arg46, but the cleavage at this site only occurred at very low rates and is unlikely to be significant in vivo.

Full Text

The Full Text of this article is available as a PDF (233.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bode W., Mayr I., Baumann U., Huber R., Stone S. R., Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 1989 Nov;8(11):3467–3475. doi: 10.1002/j.1460-2075.1989.tb08511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bode W., Meyer E., Jr, Powers J. C. Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry. 1989 Mar 7;28(5):1951–1963. doi: 10.1021/bi00431a001. [DOI] [PubMed] [Google Scholar]
  3. Brass L. F., Manning D. R., Williams A. G., Woolkalis M. J., Poncz M. Receptor and G protein-mediated responses to thrombin in HEL cells. J Biol Chem. 1991 Jan 15;266(2):958–965. [PubMed] [Google Scholar]
  4. Braun P. J., Dennis S., Hofsteenge J., Stone S. R. Use of site-directed mutagenesis to investigate the basis for the specificity of hirudin. Biochemistry. 1988 Aug 23;27(17):6517–6522. doi: 10.1021/bi00417a048. [DOI] [PubMed] [Google Scholar]
  5. Chao B. H., Kalkunte S., Maraganore J. M., Stone S. R. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochemistry. 1992 Jul 14;31(27):6175–6178. doi: 10.1021/bi00142a001. [DOI] [PubMed] [Google Scholar]
  6. Coughlin S. R., Vu T. K., Hung D. T., Wheaton V. I. Characterization of a functional thrombin receptor. Issues and opportunities. J Clin Invest. 1992 Feb;89(2):351–355. doi: 10.1172/JCI115592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davie E. W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 1991 Oct 29;30(43):10363–10370. doi: 10.1021/bi00107a001. [DOI] [PubMed] [Google Scholar]
  8. Esmon C. T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 1989 Mar 25;264(9):4743–4746. [PubMed] [Google Scholar]
  9. Furie B., Furie B. C. The molecular basis of blood coagulation. Cell. 1988 May 20;53(4):505–518. doi: 10.1016/0092-8674(88)90567-3. [DOI] [PubMed] [Google Scholar]
  10. Grand R. J., Turnell A. S., Grabham P. W. Cellular consequences of thrombin-receptor activation. Biochem J. 1996 Jan 15;313(Pt 2):353–368. doi: 10.1042/bj3130353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Greenberg J. P., Packham M. A., Guccione M. A., Harfenist E. J., Orr J. L., Kinlough-Rathbone R. L., Perry D. W., Mustard J. F. The effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents. Blood. 1979 Oct;54(4):753–765. [PubMed] [Google Scholar]
  12. Grütter M. G., Priestle J. P., Rahuel J., Grossenbacher H., Bode W., Hofsteenge J., Stone S. R. Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J. 1990 Aug;9(8):2361–2365. doi: 10.1002/j.1460-2075.1990.tb07410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Heusel J. W., Wesselschmidt R. L., Shresta S., Russell J. H., Ley T. J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 1994 Mar 25;76(6):977–987. doi: 10.1016/0092-8674(94)90376-x. [DOI] [PubMed] [Google Scholar]
  14. Higgins D. L., Lewis S. D., Shafer J. A. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. J Biol Chem. 1983 Aug 10;258(15):9276–9282. [PubMed] [Google Scholar]
  15. Hopkins P. C., Carrell R. W., Stone S. R. Effects of mutations in the hinge region of serpins. Biochemistry. 1993 Aug 3;32(30):7650–7657. doi: 10.1021/bi00081a008. [DOI] [PubMed] [Google Scholar]
  16. Howells G. L., Macey M., Curtis M. A., Stone S. R. Peripheral blood lymphocytes express the platelet-type thrombin receptor. Br J Haematol. 1993 May;84(1):156–160. doi: 10.1111/j.1365-2141.1993.tb03039.x. [DOI] [PubMed] [Google Scholar]
  17. Ishii K., Hein L., Kobilka B., Coughlin S. R. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J Biol Chem. 1993 May 5;268(13):9780–9786. [PubMed] [Google Scholar]
  18. Jakobs K. H., Grandt R. Thrombin-like inhibitory action of trypsin and trypsin-like proteases on human platelet adenylate cyclase. Eur J Biochem. 1988 Feb 15;172(1):255–260. doi: 10.1111/j.1432-1033.1988.tb13881.x. [DOI] [PubMed] [Google Scholar]
  19. Jameson G. W., Roberts D. V., Adams R. W., Kyle W. S., Elmore D. T. Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration. Biochem J. 1973 Jan;131(1):107–117. doi: 10.1042/bj1310107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jenne D. E., Tschopp J. Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev. 1988 Mar;103:53–71. doi: 10.1111/j.1600-065x.1988.tb00749.x. [DOI] [PubMed] [Google Scholar]
  21. Kettner C., Shaw E. Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone. Methods Enzymol. 1981;80(Pt 100):826–842. doi: 10.1016/s0076-6879(81)80065-1. [DOI] [PubMed] [Google Scholar]
  22. Kinlough-Rathbone R. L., Perry D. W., Packham M. A. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease. Thromb Haemost. 1995 Jan;73(1):122–125. [PubMed] [Google Scholar]
  23. Lazarowski E. R., Lapetina E. G. Persistent activation of platelet membrane phospholipase C by proteolytic action of trypsin and thrombin. Arch Biochem Biophys. 1990 Jan;276(1):265–269. doi: 10.1016/0003-9861(90)90037-y. [DOI] [PubMed] [Google Scholar]
  24. Le Bonniec B. F., Esmon C. T. Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7371–7375. doi: 10.1073/pnas.88.16.7371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Le Bonniec B. F., Guinto E. R., Esmon C. T. The role of calcium ions in factor X activation by thrombin E192Q. J Biol Chem. 1992 Apr 5;267(10):6970–6976. [PubMed] [Google Scholar]
  26. Le Bonniec B. F., Myles T., Johnson T., Knight C. G., Tapparelli C., Stone S. R. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis. Biochemistry. 1996 Jun 4;35(22):7114–7122. doi: 10.1021/bi952701s. [DOI] [PubMed] [Google Scholar]
  27. Lottenberg R., Hall J. A., Blinder M., Binder E. P., Jackson C. M. The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. Biochim Biophys Acta. 1983 Feb 15;742(3):539–557. doi: 10.1016/0167-4838(83)90272-8. [DOI] [PubMed] [Google Scholar]
  28. Lu H., Soria C., Li H., Soria J., Lijnen H. R., Perrot J. Y., Caen J. P. Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation. Thromb Haemost. 1991 Jan 23;65(1):67–72. [PubMed] [Google Scholar]
  29. Mari B., Imbert V., Belhacene N., Far D. F., Peyron J. F., Pouysségur J., Van Obberghen-Schilling E., Rossi B., Auberger P. Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. J Biol Chem. 1994 Mar 18;269(11):8517–8523. [PubMed] [Google Scholar]
  30. Masson D., Tschopp J. A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell. 1987 Jun 5;49(5):679–685. doi: 10.1016/0092-8674(87)90544-7. [DOI] [PubMed] [Google Scholar]
  31. Masson D., Tschopp J. Inhibition of lymphocyte protease granzyme A by antithrombin III. Mol Immunol. 1988 Dec;25(12):1283–1289. doi: 10.1016/0161-5890(88)90043-0. [DOI] [PubMed] [Google Scholar]
  32. Mathews I. I., Padmanabhan K. P., Ganesh V., Tulinsky A., Ishii M., Chen J., Turck C. W., Coughlin S. R., Fenton J. W., 2nd Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry. 1994 Mar 22;33(11):3266–3279. doi: 10.1021/bi00177a018. [DOI] [PubMed] [Google Scholar]
  33. Molino M., Blanchard N., Belmonte E., Tarver A. P., Abrams C., Hoxie J. A., Cerletti C., Brass L. F. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem. 1995 May 12;270(19):11168–11175. doi: 10.1074/jbc.270.19.11168. [DOI] [PubMed] [Google Scholar]
  34. Nakajima K., Powers J. C., Ashe B. M., Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J Biol Chem. 1979 May 25;254(10):4027–4032. [PubMed] [Google Scholar]
  35. Nystedt S., Emilsson K., Wahlestedt C., Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9208–9212. doi: 10.1073/pnas.91.20.9208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Padmanabhan K., Padmanabhan K. P., Tulinsky A., Park C. H., Bode W., Huber R., Blankenship D. T., Cardin A. D., Kisiel W. Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol. 1993 Aug 5;232(3):947–966. doi: 10.1006/jmbi.1993.1441. [DOI] [PubMed] [Google Scholar]
  37. Penny W. F., Ware J. A. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator. Blood. 1992 Jan 1;79(1):91–98. [PubMed] [Google Scholar]
  38. Reimers H. J., Packham M. A., Kinlough-Rathbone R. L., Mustard J. F. Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. Br J Haematol. 1973 Nov;25(5):675–689. doi: 10.1111/j.1365-2141.1973.tb01780.x. [DOI] [PubMed] [Google Scholar]
  39. Rubin H., Wang Z. M., Nickbarg E. B., McLarney S., Naidoo N., Schoenberger O. L., Johnson J. L., Cooperman B. S. Cloning, expression, purification, and biological activity of recombinant native and variant human alpha 1-antichymotrypsins. J Biol Chem. 1990 Jan 15;265(2):1199–1207. [PubMed] [Google Scholar]
  40. Ruggiero M., Lapetina E. G. Leupeptin selectively inhibits human platelet responses induced by thrombin and trypsin; a role for proteolytic activation of phospholipase C. Biochem Biophys Res Commun. 1985 Sep 30;131(3):1198–1205. doi: 10.1016/0006-291x(85)90218-9. [DOI] [PubMed] [Google Scholar]
  41. Rydel T. J., Ravichandran K. G., Tulinsky A., Bode W., Huber R., Roitsch C., Fenton J. W., 2nd The structure of a complex of recombinant hirudin and human alpha-thrombin. Science. 1990 Jul 20;249(4966):277–280. doi: 10.1126/science.2374926. [DOI] [PubMed] [Google Scholar]
  42. Rydel T. J., Tulinsky A., Bode W., Huber R. Refined structure of the hirudin-thrombin complex. J Mol Biol. 1991 Sep 20;221(2):583–601. doi: 10.1016/0022-2836(91)80074-5. [DOI] [PubMed] [Google Scholar]
  43. Scarborough R. M., Naughton M. A., Teng W., Hung D. T., Rose J., Vu T. K., Wheaton V. I., Turck C. W., Coughlin S. R. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem. 1992 Jul 5;267(19):13146–13149. [PubMed] [Google Scholar]
  44. Schafer A. I., Adelman B. Plasmin inhibition of platelet function and of arachidonic acid metabolism. J Clin Invest. 1985 Feb;75(2):456–461. doi: 10.1172/JCI111720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Schafer A. I., Maas A. K., Ware J. A., Johnson P. C., Rittenhouse S. E., Salzman E. W. Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin. J Clin Invest. 1986 Jul;78(1):73–79. doi: 10.1172/JCI112576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Selak M. A. Cathepsin G and thrombin: evidence for two different platelet receptors. Biochem J. 1994 Jan 15;297(Pt 2):269–275. doi: 10.1042/bj2970269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Selak M. A. Neutrophil elastase potentiates cathepsin G-induced platelet activation. Thromb Haemost. 1992 Nov 10;68(5):570–576. [PubMed] [Google Scholar]
  48. Skrzypczak-Jankun E., Carperos V. E., Ravichandran K. G., Tulinsky A., Westbrook M., Maraganore J. M. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. J Mol Biol. 1991 Oct 20;221(4):1379–1393. [PubMed] [Google Scholar]
  49. Stone S. R., Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry. 1986 Aug 12;25(16):4622–4628. doi: 10.1021/bi00364a025. [DOI] [PubMed] [Google Scholar]
  50. Stone S. R., Hofsteenge J. Specificity of activated human protein C. Biochem J. 1985 Sep 1;230(2):497–502. doi: 10.1042/bj2300497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Stubbs M. T., Bode W. Coagulation factors and their inhibitors. Curr Opin Struct Biol. 1994 Dec;4(6):823–832. doi: 10.1016/0959-440x(94)90263-1. [DOI] [PubMed] [Google Scholar]
  52. Suidan H. S., Bouvier J., Schaerer E., Stone S. R., Monard D., Tschopp J. Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8112–8116. doi: 10.1073/pnas.91.17.8112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Suidan H. S., Stone S. R., Hemmings B. A., Monard D. Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron. 1992 Feb;8(2):363–375. doi: 10.1016/0896-6273(92)90302-t. [DOI] [PubMed] [Google Scholar]
  54. Tam S. W., Fenton J. W., 2nd, Detwiler T. C. Platelet thrombin receptors. Binding of alpha-thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism. J Biol Chem. 1980 Jul 25;255(14):6626–6632. [PubMed] [Google Scholar]
  55. Tiefenbrunn A. J., Graor R. A., Robison A. K., Lucas F. V., Hotchkiss A., Sobel B. E. Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation. Circulation. 1986 Jun;73(6):1291–1299. doi: 10.1161/01.cir.73.6.1291. [DOI] [PubMed] [Google Scholar]
  56. Vassallo R. R., Jr, Kieber-Emmons T., Cichowski K., Brass L. F. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem. 1992 Mar 25;267(9):6081–6085. [PubMed] [Google Scholar]
  57. Vu T. K., Hung D. T., Wheaton V. I., Coughlin S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991 Mar 22;64(6):1057–1068. doi: 10.1016/0092-8674(91)90261-v. [DOI] [PubMed] [Google Scholar]
  58. Vu T. K., Wheaton V. I., Hung D. T., Charo I., Coughlin S. R. Domains specifying thrombin-receptor interaction. Nature. 1991 Oct 17;353(6345):674–677. doi: 10.1038/353674a0. [DOI] [PubMed] [Google Scholar]
  59. Weksler B. B., Jaffe E. A., Brower M. S., Cole O. F. Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells. Blood. 1989 Oct;74(5):1627–1634. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES